Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer

Inclusion Criteria: * Age ≥ 18 years old * With primary or secondary liver tumor and matching one of the following situations: * Liver Metastasis (LM): anatomopathologic diagnosis of the primary tumor * Hepatocellular Carcinoma (HCC): diagnosis achieved through biopsy or through non-invasive methods approved by AASLD criteria (Bruix, 2011) * Cholangiocarcinoma (CC): diagnosis achieved through biopsy * Other primitive hepatic tumor achieved through biopsy * Meet the requirements for SBRT treatment: * Liver Metastasis (LM): oligometastatic disease * Hepatocellular Carcinoma (HCC): non eligible lesion to curative surgery * Cholangiocarcinoma (CC): nodular lesion * Other primitive hepatic tumor: non eligible lesion to curative surgery * Able to receive a SBRT treatment according to the multidisciplinary consultation meeting * Tumor assessable with CT-scan or MRI according to mRECIST in HCC or Recist 1.1 in other situations * Affiliation to the National Social Security System * With informed and signed consent Exclusion Criteria: * Eligibility to a curative surgery according to the multidisciplinary consultation meeting * Contraindication to SBRT (especially Cirrhose Child C) * Pregnant or breastfeeding women * Patient Under guardianship or tutorship * Impossibility to submit at the study procedures due to geographic, social or mental reasons